Israeli researcher receives EU grant for development of 'electronic nose'

An Israeli researcher has been awarded a grant of € 1.73 million by the EU under its Marie Curie Excellence programme for the development of an 'electronic nose' that can sniff out cancer.

Dr Hossam Haick of the Israel Institute of Technology received the award as part of the EU's efforts to strengthen and encourage young promising scientists.

Dr Haick is 31 years old and also the recipient of the largest grant ever received from the EU by an Israeli researcher. He will be working on artificial olfactory systems or 'electronic noses' aimed at sniffing out and diagnosing cancer at the earliest possible stage before it spreads.

"Realisation of the research goal will enable creating an instrument based on nanometre-sized sensors that can diagnose different cancers and even determine at what stage the disease is," explains Dr Haick. "The diagnosis can be carried out at a very early stage even before the tumour has begun to spread. Thus, treatment will be immediate and will destroy the disease at its inception."

Electronic noses are one example of a growing research area called biomimetics, or biomimicry, which involves human-made applications patterned on natural phenomena.

As an odour is composed of molecules, each of which has a specific size and shape, each of these molecules has a receptor of a corresponding size and shape in the human nose. When a specific receptor receives a molecule, it sends a signal to the brain and the brain identifies the smell associated with that particular molecule. Electronic noses based on the biological model work in a similar manner, substituting sensors for the receptors, and transmitting the signal to a program for processing, instead of the brain.

Dr Haick intends to develop sensor arrays made of nanomaterials, understanding the fundamental chemical, physical, and electrical properties of these nanomaterials and the signal mechanism of these sensors.

He will also be developing the smallest versions of these electronic noses; the 'e-nose on chip', which is a single computer chip containing both the sensors and the processing components.

In addition, to targeting the early diagnosis, detection and screening of a disease, artificial olfactory systems are used in environmental-monitoring, the food industries and security.

For further information, please visit: Technion - Israel Institute of Technology

Copyright ©European Communities, 2006
Neither the Office for Official Publications of the European Communities, nor any person acting on its behalf, is responsible for the use, which might be made of the attached information. The attached information is drawn from the Community R&D Information Service (CORDIS). The CORDIS services are carried on the CORDIS Host in Luxembourg - http://cordis.europa.eu. Access to CORDIS is currently available free-of-charge.

Most Popular Now

Philips Foundation 2024 Annual Report: E…

Marking its tenth anniversary, Philips Foundation released its 2024 Annual Report, highlighting a year in which the Philips Foundation helped provide access to quality healthcare for 46.5 million people around...

New AI Transforms Radiology with Speed, …

A first-of-its-kind generative AI system, developed in-house at Northwestern Medicine, is revolutionizing radiology - boosting productivity, identifying life-threatening conditions in milliseconds and offering a breakthrough solution to the global radiologist...

Scientists Argue for More FDA Oversight …

An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient safety when it comes to artificial intelligence-driven medical...

New Research Finds Specific Learning Str…

If data used to train artificial intelligence models for medical applications, such as hospitals across the Greater Toronto Area, differs from the real-world data, it could lead to patient harm...

Giving Doctors an AI-Powered Head Start …

Detection of melanoma and a range of other skin diseases will be faster and more accurate with a new artificial intelligence (AI) powered tool that analyses multiple imaging types simultaneously...

AI Agents for Oncology

Clinical decision-making in oncology is challenging and requires the analysis of various data types - from medical imaging and genetic information to patient records and treatment guidelines. To effectively support...

Patients say "Yes..ish" to the…

As artificial intelligence (AI) continues to be integrated in healthcare, a new multinational study involving Aarhus University sheds light on how dental patients really feel about its growing role in...

Brains vs. Bytes: Study Compares Diagnos…

A University of Maine study compared how well artificial intelligence (AI) models and human clinicians handled complex or sensitive medical cases. The study published in the Journal of Health Organization...

'AI Scientist' Suggests Combin…

An 'AI scientist', working in collaboration with human scientists, has found that combinations of cheap and safe drugs - used to treat conditions such as high cholesterol and alcohol dependence...

Start-ups in the Spotlight at MEDICA 202…

17 - 20 November 2025, Düsseldorf, Germany. MEDICA, the leading international trade fair and platform for healthcare innovations, will once again confirm its position as the world's number one hotspot for...